Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance

被引：23

作者：

Ferreira, Vanessa M. ^{[1
]}

Plein, Sven ^{[2
]}

Wong, Timothy C. ^{[3
]}

Tao, Qian ^{[4
]}

Raisi-Estabragh, Zahra ^{[5
]}

Jain, Supriya S. ^{[6
]}

Han, Yuchi ^{[7
]}

Ojha, Vineeta ^{[8
]}

Bluemke, David A. ^{[9
]}

Hanneman, Kate ^{[10
]}

Weinsaft, Jonathan ^{[11
]}

Vidula, Mahesh K. ^{[12
]}

Ntusi, Ntobeko A. B. ^{[13
,14
,15
]}

Schulz-Menger, Jeanette ^{[16
,17
]}

Kim, Jiwon ^{[11
]}

机构：

[1] Univ Oxford, Radcliffe Dept Med,Univ Oxford Ctr Clin Magnet Re, Natl Inst Hlth Res Oxford Biomed Res Ctr,Div Card, Oxford Univ Hosp NHS Fdn Trust,Oxford British Hea, Oxford, England

[2] Univ Leeds, Dept Biomed Imaging Sci, Leeds, W Yorkshire, England

[3] Univ Pittsburgh, Sch Med, Dept Med, Div Cardiol, Pittsburgh, PA 15213 USA

[4] Delft Univ Technol, Dept Imaging Phys, Delft, Netherlands

[5] Queen Mary Univ London, William Harvey Res Inst, NIHR Barts Biomed Res Ctr, Charterhouse Sq, London EC1M 6BQ, England

[6] New York Med Coll, Maria Fareri Childrens Hosp, Westchester Med Ctr, Div Pediat Cardiol,Dept Pediat, New York, NY USA

[7] Ohio State Univ, Wexner Med Ctr, Cardiovasc Med, Columbus, OH USA

[8] All India Inst Med Sci, Dept Cardiovasc Radiol & Endovascular Intervent, New Delhi, India

[9] Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Madison, WI USA

[10] Univ Toronto, Toronto Gen Hosp, Dept Med Imaging, Toronto, ON, Canada

[11] Weill Cornell Med Coll, Weill Cornell Med New York Presbyterian Hosp, Dept Med, Div Cardiol, New York, NY 10021 USA

[12] Univ Penn, Div Cardiovasc Med, Philadelphia, PA USA

[13] Univ Cape Town, Div Cardiol, Dept Med, Cape Town, South Africa

[14] Groote Schuur Hosp, Cape Town, South Africa

[15] Univ Cape Town, Cape Heart Inst, South African Med Res Council Extramural Unit Int, Cape Town, South Africa

[16] Charite, Expt & Clin Res Ctr, Working Grp Cardiovasc Magnet Resonance, Joint Cooperat Charite & MDC, Berlin, Germany

[17] Helios Hosp Berlin Buch, Dept Cardiol & Nephrol, Berlin, Germany

来源：

JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE | 2023年 / 25卷 / 01期

基金：

美国国家卫生研究院; 新加坡国家研究基金会; 英国医学研究理事会;

关键词：

Cardiovascular magnetic resonance; COVID-19; SARS-CoV-2; Cardiac complications; Myocarditis; Myocardial infarction; Microinfarctions; Thrombotic complications; Multisystem inflammatory syndrome; Diagnostic criteria; MULTISYSTEM INFLAMMATORY SYNDROME; EXTRACELLULAR VOLUME FRACTION; MYOCARDIAL INJURY; PROGNOSTIC VALUE; IRREVERSIBLE INJURY; MULTICENTER; CHILDREN; RISK; AGE; QUANTIFICATION;

D O I：

10.1186/s12968-023-00933-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic that has affected nearly 600 million people to date across the world. While COVID-19 is primarily a respiratory illness, cardiac injury is also known to occur. Cardiovascular magnetic resonance (CMR) imaging is uniquely capable of characterizing myocardial tissue properties in-vivo, enabling insights into the pattern and degree of cardiac injury. The reported prevalence of myocardial involvement identified by CMR in the context of COVID-19 infection among previously hospitalized patients ranges from 26 to 60%. Variations in the reported prevalence of myocardial involvement may result from differing patient populations (e.g. differences in severity of illness) and the varying intervals between acute infection and CMR evaluation. Standardized methodologies in image acquisition, analysis, interpretation, and reporting of CMR abnormalities across would likely improve concordance between studies. This consensus document by the Society for Cardiovascular Magnetic Resonance (SCMR) provides recommendations on CMR imaging and reporting metrics towards the goal of improved standardization and uniform data acquisition and analytic approaches when performing CMR in patients with COVID-19 infection.

引用

页数：17

共 129 条

[31] Contrast-enhanced magnetic resonance imaging of myocardium at risk - Distinction between reversible and irreversible injury throughout infarct healing [J].